Trandolapril
NDC 68180-566, Trandolapril, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-566
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077522
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-566 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANDOLAPRIL1 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-566-01 | 68180056601 | 100 TABLET in 1 BOTTLE (68180-566-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8143a6cf-dadc-4ef7-a8db-d16d7150ad34NADAC price for package 68180056601
GET /v1/drugs/nadac/68180056601
Use it
Look up 68180-566 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-566 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-566. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.